Development of a biomarker-based calculator to predict the probability to achieve a pathologic complete response after neoadjuvant pembrolizumab in muscle-invasive bladder cancer

被引：0
|
作者：
Marandino, L. [1 ]
Bandini, M. [2 ,3 ]
Madison, R. [4 ]
Raggi, D. [1 ]
Gallina, A. [2 ,3 ]
Colecchia, M. [5 ]
Luciano, R. [6 ,7 ]
Giannatempo, P. [1 ]
Fare, E. [1 ]
Pederzoli, F. [7 ,8 ]
Bianchi, M. [7 ,9 ]
Colombo, R. [7 ,8 ]
Capitanio, U. [7 ,8 ]
Ali, S. M. [4 ]
Chung, J. H. [4 ]
Ross, J. [4 ]
Salonia, A. [7 ,8 ]
Briganti, A. [7 ,8 ]
Montorsi, F. [2 ,3 ]
Necchi, A. [1 ]
机构：
[1] Fdn IRCCS Ist Nazl Tumori, Dept Med Oncol, Milan, Italy
[2] Univ Vita Salute San Raffaele, Unit Urol, Div Oncol, Milan, Italy
[3] Urol Res Inst, Milan, Italy
[4] Fdn Med, Clin Bioinformat Operat, Cambridge, MA USA
[5] Fdn IRCCS Ist Nazl Tumori, Pathol, Milan, Italy
[6] Univ Vita Salute San Raffaele, Pathol, Milan, Italy
[7] Urol Res Inst, Milan, Italy
[8] Univ Vita Salute San Raffaele, Unit Urol, Milan, Italy
[9] Univ Vita Salute San Raffaele, Genet & Cell Biol, Milan, Italy
来源：
ANNALS OF ONCOLOGY | 2019年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
31P
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Development of a composite biomarker-based calculator to predict the probability of pathologic complete response (pT0) after neoadjuvant pembrolizumab (pembro) in muscle invasive bladder cancer (MIBC)
    Necchi, Andrea
    Meeks, Joshua J.
    Bandini, Marco
    Fall, Leigh Ann
    Raggi, Daniele
    Briganti, Alberto
    Fare, Elena
    Giannatempo, Patrizia
    McLaughlin, Kimberly A.
    Das, Arighno
    Marandino, Laura
    Gallina, Andrea
    Salonia, Andrea
    Gandaglia, Giorgio
    Fossati, Nicola
    Ross, Jeffrey S.
    Montorsi, Francesco
    Dittamore, Ryan
    Davicioni, Elai
    Gibb, Ewan
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [2] Development of a biomarker-based nomogram to predict the pathologic response to neoadjuvant pembrolizumab in muscle-invasive urothelial bladder cancer (MIBC).
    Necchi, Andrea
    Bandini, Marco
    Raggi, Daniele
    Briganti, Alberto
    Fare, Elena
    Gallina, Andrea
    Colombo, Renzo
    Bianchi, Marco
    Colecchia, Maurizio
    Luciano, Roberta
    Salonia, Andrea
    Pederzoli, Filippo
    Ross, Jeffrey S.
    Madison, Russell
    Montorsi, Francesco
    Ali, Siraj M.
    Chung, Jon H.
    [J]. CLINICAL CANCER RESEARCH, 2020, 26 (15) : 28 - 29
  • [3] Predicting the Pathologic Complete Response After Neoadjuvant Pembrolizumab in Muscle-Invasive Bladder Cancer
    Bandini, Marco
    Ross, Jeffrey S.
    Raggi, Daniele
    Gallina, Andrea
    Colecchia, Maurizio
    Luciano, Roberta
    Giannatempo, Patrizia
    Fare, Elena
    Pederzoli, Filippo
    Bianchi, Marco
    Colombo, Renzo
    Gandaglia, Giorgio
    Fossati, Nicola
    Marandino, Laura
    Capitanio, Umberto
    Deho', Federico
    Ali, Siraj M.
    Madison, Russell
    Chung, Jon H.
    Salonia, Andrea
    Briganti, Alberto
    Montorsi, Francesco
    Necchi, Andrea
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2021, 113 (01) : 48 - 53
  • [4] Re: Predicting the Pathologic Complete Response after Neoadjuvant Pembrolizumab in Muscle-Invasive Bladder Cancer Editorial Comment
    Chang, Sam S.
    [J]. JOURNAL OF UROLOGY, 2022, 207 (05): : 1154 - 1155
  • [5] Urothelial phase CT for assessment of pathologic complete response after neoadjuvant chemotherapy in muscle-invasive bladder cancer
    Choi, Se Jin
    Park, Kye Jin
    Lee, Goeun
    Kim, Mi-hyun
    Kim, Jeong Kon
    [J]. EUROPEAN JOURNAL OF RADIOLOGY, 2020, 126
  • [6] Modelling cost-effectiveness of a biomarker-based approach to neoadjuvant chemotherapy for muscle-invasive bladder cancer
    Lotan, Yair
    Woldu, Solomon L.
    Sanli, Oner
    Black, Peter
    Milowsky, Matthew I.
    [J]. BJU INTERNATIONAL, 2018, 122 (03) : 434 - 440
  • [7] Predicting Complete Response to Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer
    Miyagi, Hiroko
    Kwenda, Elizabeth
    Ramnaraign, Brian H.
    Chatzkel, Jonathan A.
    Brisbane, Wayne G.
    O'Malley, Padraic
    Crispen, Paul L.
    [J]. CANCERS, 2023, 15 (01)
  • [8] Impact of angiotensin inhibitors on pathologic complete response with neoadjuvant chemotherapy (NAC) for muscle-invasive bladder cancer (MIBC).
    Thomas, Jonathan
    Pond, Gregory Russell
    Curran, Catherine
    Freeman, Dory
    Ravi, Praful
    Mossanen, Matthew
    Preston, Mark A.
    Steele, Graeme S.
    Mantia, Charlene
    McGregor, Bradley Alexander
    Jain, Rakesh K.
    Sonpavde, Guru
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [9] Association of an immune gene signature with pathologic response and outcome after neoadjuvant pembrolizumab (pembro), compared to neoadjuvant chemotherapy (NAC), in muscle-invasive bladder cancer (MIBC)
    Necchi, Andrea
    Raggi, Daniele
    Briganti, Alberto
    Fare, Elena
    Giannatempo, Patrizia
    Marandino, Laura
    Bianchi, Marco
    Gallina, Andrea
    Salonia, Andrea
    Gandaglia, Giorgio
    Fossati, Nicola
    Capitanio, Umberto
    Montorsi, Francesco
    Boormans, Joost L.
    Liu, Yang
    de Jong, Joep
    Black, Peter C.
    Dittamore, Ryan
    Davicioni, Elai
    Gibb, Ewan
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [10] Platinum Concentration and Pathologic Response to Cisplatin-Based Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer
    Guancial, Elizabeth A.
    Kilari, Deepak
    Xiao, Guang-Qian
    Abu-Farsakh, Sohaib H.
    Baran, Andrea
    Messing, Edward M.
    Kim, Eric S.
    [J]. PLOS ONE, 2016, 11 (05):
12345